The nephropathy of sickle cell trait and sickle cell disease

KI Ataga, SL Saraf, VK Derebail - Nature Reviews Nephrology, 2022 - nature.com
Sickle cell syndromes, including sickle cell disease (SCD) and sickle cell trait, are
associated with multiple kidney abnormalities. Young patients with SCD have elevated …

Genetic variation and sickle cell disease severity: a systematic review and meta-analysis

JK Kirkham, JH Estepp, MJ Weiss… - JAMA Network …, 2023 - jamanetwork.com
Importance Sickle cell disease (SCD) is a monogenic disorder, yet clinical outcomes are
influenced by additional genetic factors. Despite decades of research, the genetics of SCD …

[HTML][HTML] New insights into the role of heme oxygenase-1 in acute kidney injury

M Nath, A Agarwal - Kidney research and clinical practice, 2020 - ncbi.nlm.nih.gov
Acute kidney injury (AKI) is attended by injury-related biomarkers appearing in the urine and
serum, decreased urine output, and impaired glomerular filtration rate. AKI causes increased …

Heme oxygenase 1: A defensive mediator in kidney diseases

A Grunenwald, LT Roumenina, M Frimat - International journal of …, 2021 - mdpi.com
The incidence of kidney disease is rising, constituting a significant burden on the healthcare
system and making identification of new therapeutic targets increasingly urgent. The heme …

[PDF][PDF] Genetic modifiers of sickle cell disease

T Pincez, AE Ashley-Koch, G Lettre, MJ Telen - … /Oncology Clinics of North …, 2022 - Elsevier
Studies of genetic variants and their associations with disease outcomes using recent
molecular technology advances and the broad variety of statistical methodologies available …

Differences in the circulating proteome in individuals with versus without sickle cell trait

Y Cai, N Franceschini, A Surapaneni… - Clinical Journal of the …, 2023 - journals.lww.com
Background: Sickle cell trait affects∼ 8% of African American individuals, along with many
other individuals with ancestry from malaria-endemic regions worldwide. While traditionally …

End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings

AT Farrell, J Panepinto, AA Desai, AA Kassim… - Blood …, 2019 - ashpublications.org
To address the global burden of sickle cell disease and the need for novel therapies, the
American Society of Hematology partnered with the US Food and Drug Administration to …

Identification of biomarkers, immune infiltration landscape, and treatment targets of ischemia–reperfusion acute kidney injury at an early stage by bioinformatics …

R You, Z Heyang, Y Ma, P Xia, H Zheng, J Lin, P Ji… - Hereditas, 2022 - Springer
Background Mechanisms underlying ischemia/reperfusion injury-acute kidney injury (IRI-
AKI) are not fully elucidated. We conducted an integrative analysis of IRI-AKI by …

HMOX1 genetic polymorphisms and outcomes in infectious disease: A systematic review

FW Hamilton, J Somers, RE Mitchell, P Ghazal… - PLoS …, 2022 - journals.plos.org
Introduction Heme-oxygenase 1 (HMOX1) is a critical stress response gene that catalyzes
the multistep oxidation of heme. A GT (n) repeat of variable length in the promoter in has …

Hyperkalemia and metabolic acidosis occur at a higher eGFR in sickle cell disease

SL Saraf, VK Derebail, X Zhang, RF Machado… - Kidney360, 2022 - journals.lww.com
Background People with sickle cell disease (SCD) have an elevated estimated glomerular
filtration rate (eGFR) compared with the general population, and this may alter the usual …